Vanderbilt University’s Research Associate Professor of Pharmacology, Amanda Linkous, received a research grant from the Merck Research Laboratories SEEDS program to study therapeutic intervention points for preventing lung cancer metastasis in the brain. Despite common treatments, many cases of lung cancer spread to the brain, leading to challenges in treatment. Linkous aims to use 3D organoid models and computational analyses to understand how tumor cells adapt to the brain environment. By focusing on organ-specific vulnerabilities to target tumor cells, this research could revolutionize treatment approaches for metastatic lung cancer and potentially impact other lung and brain-related cancers. Linkous will collaborate with Merck scientists to advance this innovative research, leveraging resources from Vanderbilt Technologies for Advanced Genomics. Vanderbilt's Center for Technology Transfer and Commercialization (CTTC) and the Industry Collaborations team are dedicated to promoting impactful research collaborations with industry partners like Merck to advance scientific discoveries.
Original article: Linkous advances lung cancer research with Merck Research Laboratories Scientific Engagement and Emerging Discovery Science program